The Effect of Mild Agonist Stimulation on the Platelet Reactivity in Patients with Type 2 Diabetes Mellitus

Overview

Journal BMC Endocr Disord

Publisher Biomed Central

Specialty Endocrinology

Date 2019 Jun 16

PMID 31200678

Citations 4

Authors

Razie Mahmoodian

Morteza Salimian

Mohsen Hamidpour

Ali Akbar Khadem-Maboudi

Ahmad Gharehbaghian

Affiliations

Soon will be listed here.

Abstract

Background: Patients with type 2 diabetes mellitus (T2DM) have accelerated atherosclerosis as a pro thrombotic state that is associated with the platelet activation priming. Platelets, which undergo the continuous mild stimulation, may lose their sensitivity to react to a strong stimulation. The present study aimed to investigate activation responses of platelets to mild and subsequent strong stimulations in patients with T2DM and healthy individuals.

Methods: Blood samples, which were taken from 40 patients with T2DM and 35 healthy individuals, were collected into the citrate containing tubes. The samples were subjected to the soft centrifugation to prepare the platelet rich plasma (PRP). Platelets in PRP samples were treated at a low (1 μM) concentration and then at a high (10 μM) concentration of ADP. Before and after stimulation with different doses of ADP, levels of CD62P expression and formation of platelet micro particles (PMPs) were measured using a flow cytometry method.

Results: The platelets from patients with T2DM had higher levels of CD62P expression before any stimulation (P = 0.003) than control samples. Platelets, which underwent the mild stimulation, indicated lower responses to CD62P expression, but higher PMPs formation after stimulation with high dose of ADP. Patients with T2DM had higher platelet micro particles in all states with the ADP stimulation. (P = 0.004, SD: ±74.52).

Conclusions: The flow cytometry data indicated that platelets were pre-active and associated with metabolic conditions in patients with type 2 diabetes mellitus. The induction of desensitization state helped platelets to reduce the platelet activation and sensitivity to ADP in a diabetic environment. Furthermore, the production of platelets micro-particles was high in the patients; and desensitized platelets were more susceptible to shedding of micro-particles.

Citing Articles

Platelets camouflaged nanovehicle improved bladder cancer immunotherapy by triggering pyroptosis.

Tian J, Gao M, Zhu J, Xu H, Ji H, Xia D Theranostics. 2024; 14(17):6692-6707.

PMID: 39479459 PMC: 11519802. DOI: 10.7150/thno.99040.

Platelet-derived lipids promote insulin secretion of pancreatic β cells.

Karwen T, Kolczynska-Matysiak K, Gross C, Loffler M, Friedrich M, Loza-Valdes A EMBO Mol Med. 2023; 15(9):e16858.

PMID: 37490001 PMC: 10493578. DOI: 10.15252/emmm.202216858.

Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice.

Marcinczyk N, Misztal T, Chabielska E, Gromotowicz-Poplawska A Sci Rep. 2023; 13(1):932.

PMID: 36650229 PMC: 9845220. DOI: 10.1038/s41598-023-28225-8.

Understanding the Activation of Platelets in Diabetes and Its Modulation by Allyl Methyl Sulfide, an Active Metabolite of Garlic.

Malladi N, Johny E, Uppulapu S, Tiwari V, Alam M, Adela R J Diabetes Res. 2022; 2021:6404438.

PMID: 35127948 PMC: 8808240. DOI: 10.1155/2021/6404438.

References

van der Pol E, Boing A, Gool E, Nieuwland R . Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J Thromb Haemost. 2015; 14(1):48-56. DOI: 10.1111/jth.13190. View

Kakouros N, Rade J, Kourliouros A, Resar J . Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. 2011; 2011:742719. PMC: 3159301. DOI: 10.1155/2011/742719. View

Hardy A, Conley P, Luo J, Benovic J, Poole A, Mundell S . P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood. 2005; 105(9):3552-60. DOI: 10.1182/blood-2004-07-2893. View

Siljander P, Munnix I, Smethurst P, Deckmyn H, Lindhout T, Ouwehand W . Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood. 2003; 103(4):1333-41. DOI: 10.1182/blood-2003-03-0889. View

Schneider D . Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care. 2009; 32(4):525-7. PMC: 2660482. DOI: 10.2337/dc08-1865. View

Holme S, Holmsen H . ADP-induced refractory state of platelets in vitro. I. Methodological studies on aggregation in platelet rich plasma. Scand J Haematol. 1975; 15(2):96-103. DOI: 10.1111/j.1600-0609.1975.tb01060.x. View

Melki I, Tessandier N, Zufferey A, Boilard E . Platelet microvesicles in health and disease. Platelets. 2017; 28(3):214-221. DOI: 10.1080/09537104.2016.1265924. View

Creager M, Luscher T, Cosentino F, Beckman J . Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003; 108(12):1527-32. DOI: 10.1161/01.CIR.0000091257.27563.32. View

Lemkes B, Hermanides J, DeVries J, Holleman F, Meijers J, Hoekstra J . Hyperglycemia: a prothrombotic factor?. J Thromb Haemost. 2010; 8(8):1663-9. DOI: 10.1111/j.1538-7836.2010.03910.x. View

10.

Shantsila E, Kamphuisen P, Lip G . Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost. 2010; 8(11):2358-68. DOI: 10.1111/j.1538-7836.2010.04007.x. View

11.

Alexandru N, Badila E, Weiss E, Cochior D, Stepien E, Georgescu A . Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players. Biochem Biophys Res Commun. 2016; 472(1):1-10. DOI: 10.1016/j.bbrc.2016.02.038. View

12.

Morel O, Jesel L, Abbas M, Morel N . Prothrombotic changes in diabetes mellitus. Semin Thromb Hemost. 2013; 39(5):477-88. DOI: 10.1055/s-0033-1343888. View

13.

Lunkes G, Lunkes D, Stefanello F, Morsch A, Morsch V, Mazzanti C . Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res. 2003; 109(4):189-94. DOI: 10.1016/s0049-3848(03)00178-6. View

14.

Bunemann M, Lee K, Roseberry A, Hosey M . Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu Rev Physiol. 1999; 61:169-92. DOI: 10.1146/annurev.physiol.61.1.169. View

15.

Ferroni P, Basili S, Falco A, Davi G . Platelet activation in type 2 diabetes mellitus. J Thromb Haemost. 2004; 2(8):1282-91. DOI: 10.1111/j.1538-7836.2004.00836.x. View

16.

Martinez M, Tual-Chalot S, Leonetti D, Andriantsitohaina R . Microparticles: targets and tools in cardiovascular disease. Trends Pharmacol Sci. 2011; 32(11):659-65. DOI: 10.1016/j.tips.2011.06.005. View

17.

Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen M, Tuomi T . Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes. 2000; 49(6):975-80. DOI: 10.2337/diabetes.49.6.975. View

18.

Pierce G . Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. Am J Pathol. 2001; 159(2):399-403. PMC: 1850546. DOI: 10.1016/S0002-9440(10)61709-9. View

19.

Osende J, Badimon J, Fuster V, Herson P, Rabito P, Vidhun R . Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol. 2001; 38(5):1307-12. DOI: 10.1016/s0735-1097(01)01555-8. View

20.

Vinik A, Erbas T, Park T, Nolan R, Pittenger G . Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001; 24(8):1476-85. DOI: 10.2337/diacare.24.8.1476. View